Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients - ScienceDirect

Description

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma - ScienceDirect

Current Advances in Clinical Application of Liquid Biopsy

Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies - ScienceDirect

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma - ScienceDirect

PDF) Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients

Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases

Multimodal analysis of ctDNA methylation and fragmentomic profiles enhances detection of nonmetastatic colorectal cancer

Circulating cell-free DNA for cancer early detection - ScienceDirect

Cancers, Free Full-Text

$ 15.99USD
Score 4.5(649)
In stock
Continue to book